Technetium Tc-99m tetrofosmin
Term · Oncology and biomedicine · MLC-T-ONC-017034
A radiopharmaceutical consisting of tetrofosmin, composed of two bidentate diphosphine ligands chelating the metastable radioisotope technetium Tc-99 (99mTc), with potential imaging activity upon SPECT (single photon emission computed tomography). Upon administration, technetium Tc 99m tetrofosmin is preferentially taken up by, and accumulates in, myocardial cells. Upon imaging, myocardial cells can be visualized and changes in ischemia and/or perfusion can be detected.
| Identifier | MLC-T-ONC-017034 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | technetium Tc 99m Tetrofosmin |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017034",
"term": "Technetium Tc-99m tetrofosmin",
"field": "Oncology and biomedicine",
"definition": "A radiopharmaceutical consisting of tetrofosmin, composed of two bidentate diphosphine ligands chelating the metastable radioisotope technetium Tc-99 (99mTc), with potential imaging activity upon SPECT (single photon emission computed tomography). Upon administration, technetium Tc 99m tetrofosmin is preferentially taken up by, and accumulates in, myocardial cells. Upon imaging, myocardial cells can be visualized and changes in ischemia and/or perfusion can be detected.",
"synonyms": [
"technetium Tc 99m Tetrofosmin"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/technetium-tc-99m-tetrofosmin/"
}
Record 16,090 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.